Detalles de la búsqueda
1.
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis.
Neurol Sci;
44(3): 803-808, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36567409
2.
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis.
J Neurol Neurosurg Psychiatry;
2022 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36180219
3.
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies.
Mult Scler;
28(13): 2106-2111, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35735030
4.
Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey.
Neurol Sci;
43(2): 1197-1205, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34283343
5.
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation.
Mult Scler;
27(12): 1939-1947, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33565913
6.
Skin Thickening of the Scalp and High Signal Intensity of Dentate Nucleus in Multiple Sclerosis: Association With Linear Versus Macrocyclic Gadolinium-Based Contrast Agents Administration.
Invest Radiol;
58(3): 223-230, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36729383
7.
A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients.
Clin Transl Immunology;
12(3): e1434, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36969367
8.
Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus.
Mult Scler Relat Disord;
57: 103334, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158447
9.
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection.
Mult Scler Relat Disord;
57: 103345, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158454
10.
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab.
Neurol Neuroimmunol Neuroinflamm;
9(3)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35273036
11.
T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers.
Mult Scler Relat Disord;
55: 103157, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34418737
12.
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications.
Front Immunol;
12: 796482, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35111162
13.
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis.
Mult Scler Relat Disord;
45: 102359, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32663793
Resultados
1 -
13
de 13
1
Próxima >
>>